Topical sirolimus in dermatology: a systematic review

西罗莫司 皮肤病科 医学 不利影响 药理学 外科
作者
Usamah M Afzal,Mohammad Alazemi,Omar M. E. Ali,Faisal R. Ali,John T. Lear
出处
期刊:Clinical and Experimental Dermatology [Oxford University Press]
卷期号:50 (1): 1-11 被引量:1
标识
DOI:10.1093/ced/llae275
摘要

Abstract Topical sirolimus is increasingly utilized off-licence to manage various dermatological conditions while avoiding typical adverse effects associated with systemic sirolimus. However, widespread use is limited by a highly heterogeneous evidence base of mixed quality. Our aim was to evaluate the current evidence base for the indications, efficacy and safety profile of topical sirolimus in dermatology. A literature search was conducted from 2005 to 4 July 2023, of English-language studies, with the following databases consulted: MEDLINE, PubMed, Embase, CENTRAL and EBSCO. Key words included ‘topical’, ‘rapamycin’, ‘sirolimus’ and ‘dermatology’. Data on drug efficacy, concentration, side-effects, cointerventions and follow-up were extracted. The search identified 202 studies, 71 of which met the inclusion criteria. Efficacy of topical sirolimus was demonstrated in facial angiofibromas (799 patients) compared with placebo across multiple randomized controlled trials, with a predominant concentration of 0.1%. Evidence was mixed for use of sirolimus in port-wine stains (61 patients), with evidence of effectiveness for combined sirolimus and pulsed-dye laser. Multiple case reports demonstrated clinical improvement with topical sirolimus in cutaneous vascular abnormalities (33 patients) at a higher concentration of 1%. Other applications of topical sirolimus were predominantly case reports, demonstrating generally favourable outcomes. Topical sirolimus was generally well tolerated; most reported adverse effects were localized irritation and pruritus. Ointment-based preparations and once-daily dosing appeared to confer a better side-effect profile. Most high-quality data pertain to the efficacy of topical sirolimus in treating facial angiofibromas in tuberous sclerosis. Outcomes are generally promising in other indications, with good tolerability, but data quality is mixed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
雪糕刺客发布了新的文献求助10
1秒前
1秒前
1秒前
张wwww完成签到,获得积分10
2秒前
小巧怀薇完成签到,获得积分10
2秒前
关我屁事完成签到 ,获得积分10
3秒前
librahapper发布了新的文献求助10
4秒前
青青草地完成签到 ,获得积分10
4秒前
4秒前
科研通AI6.3应助等待秋尽采纳,获得10
5秒前
酷波er应助雪糕刺客采纳,获得10
5秒前
5秒前
yyyy完成签到,获得积分10
6秒前
盛小铃发布了新的文献求助10
6秒前
zzyzzyz完成签到,获得积分10
6秒前
6秒前
dian发布了新的文献求助10
7秒前
临泉完成签到,获得积分10
8秒前
8秒前
汉堡包应助汤孤风采纳,获得10
8秒前
8秒前
zz发布了新的文献求助10
8秒前
9秒前
9秒前
10秒前
缥缈向松完成签到,获得积分10
10秒前
魏魏发布了新的文献求助10
12秒前
jackenlu发布了新的文献求助10
13秒前
搜集达人应助盛小铃采纳,获得10
13秒前
优美的芷文完成签到,获得积分10
14秒前
iiiau发布了新的文献求助10
14秒前
韩琳发布了新的文献求助10
14秒前
科研通AI6.4应助dian采纳,获得10
14秒前
molihuakai应助WXN采纳,获得10
15秒前
15秒前
青禾发布了新的文献求助10
16秒前
所所应助sober采纳,获得10
16秒前
18秒前
18秒前
所所应助光亮的修杰采纳,获得10
19秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
Organic Reactions, Volume 116 1000
Current concepts in cutaneous toxicity : proceedings of the Fourth Conference on Cutaneous Toxicity, Washington, D.C., May 9-11, 1979 1000
ズームレンズの光学設計に関する研究 800
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7277030
求助须知:如何正确求助?哪些是违规求助? 8898117
关于积分的说明 18816203
捐赠科研通 6949671
什么是DOI,文献DOI怎么找? 3206395
关于科研通互助平台的介绍 2377413
邀请新用户注册赠送积分活动 2181327